Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of HJ787 ointment in patients with acne vulgaris
CTR20250633Phase 2Active
- Sponsor
- Huajian Future
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HJ787 in acne vulgaris, sponsored by Huajian Future. Started Feb 2025; status: active.
02
Drugs
HJ787
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20250633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250633.